Kodak is back. The once-giant corporation responsible for most twentieth century American memories is now reinventing itself as a drug company. Executive Chairman James Continenza explains Kodak’s comeback amid the coronavirus pandemic. SEC Chairman Jay Clayton discusses corporate hygiene as company boards cash in on their own holdings. He issues a word of advice for investors looking to get involved in SPACs, and urges transparency among corporate management. Plus, former FDA Commissioner Dr. Scott Gottlieb discusses the race for a Covid vaccine and planning schools’ fall semesters.